STI has focused its early efforts to bring products to the market with our state of the art on-site R&D laboratory that is fully equipped to develop multiple products at a time in a wide range of dosage forms. Our strong R&D team, with expertise in complex products, ensures the development of high quality products while collaborating and receiving input from our commercial team to ensure that we meet the patient’s needs. STI’s R&D expertise includes the development of complex drug molecules such as peptides and cytotoxic molecules, enabling us to develop these products for the US market. Our onsite scientists are engaged in formulation development, analytical method development and play a leading role in the successful technology transfer to our partner Contract Manufacturing Organizations.